Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Rubius Therapeutics Inc (RUBY)

Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2018
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -179,670 -196,550 -167,730 -163,460 -89,200
Net Income Growth +8.59% -17.18% -2.61% -83.25% -103.42%

Balance Sheet

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2018
Total Assets 23,070 318,020 277,790 394,840 479,110
Total Assets Growth -92.75% +14.48% -29.64% -17.59% +344.90%
Total Liabilities 7,940 139,240 136,230 120,630 86,100
Total Liabilities Growth -94.30% +2.21% +12.93% +40.10% +643.52%

Cash Flow

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2018
Operating Cash Flow -150,140 -145,120 -127,650 -110,440 -58,340
Operating Cash Flow Growth -3.46% -13.69% -15.58% -89.30% -165.91%
Net Cash Flow -212,670 134,680 -730 -215,790 204,850
Change in Net Cash Flow -257.91% +18,549.31% +99.66% -205.34% +110.10%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot